Geropharm insulin company private revenue?

Geropharm (Героварм) is a private Russian pharmaceutical company that produces insulin and other products. Because it is privately held, it does not publish audited financial statements for public consumption, so there isn’t a publicly verifiable “private revenue” figure like you’d see for a public company.

If you need an approximate figure or the latest numbers, you’d typically have to look at paid business databases or the company’s own disclosures, which may be limited. Here are practical options:

- Russian corporate registers: Search in the Unified State Register of Legal Entities (ЕГРЮЛ) for ООО Генерофарм and any filed financial statements (баланс, отчет о финансовых результатах). Smaller private firms may file minimal statements.
- B2B / business info services: SPARK-Interfax, Kontur.Focus, Rusprofile, or similar databases often have revenue estimates or basic financials for private Russian companies (may require a subscription).
- News and press releases: Check Russian business press or company press releases for any disclosed figures (even if approximate).
- Direct inquiry: If you have a particular reason (investment, due diligence), you could contact the company’s management or investor relations (if they offer a contact or document request).

If you’d like, tell me the year range and whether you want RUB or USD figures, and I can help you draft a targeted search plan or interpret any sources you find.